Literature DB >> 17970197

Activation of kappa-opioid receptor as a method for prevention of ischemic and reperfusion arrhythmias: role of protein kinase C and K(ATP) channels.

A Yu Lishmanov1, L N Maslov, T V Lasukova, D Crawford, T M Wong.   

Abstract

Intravenous pretreatment with kappa-opioid receptor antagonist (-)-U-50,488 (1 mg/kg) improved heart resistance to the arrhythmogenic effect of coronary occlusion and reperfusion. Selective kappa1-opioid receptor antagonist norbinaltorphimine and nonselective blocker of peripheral opioid receptors methylnaloxone abolished this antiarrhythmic effect. Preliminary blockade of protein kinase C with chelerythrine or inhibition of ATP-dependent K+ channels (K(ATP) channels) with glybenclamide abolished the antiarrhythmic effect of kappa-opioid receptor activation. Selective inhibitor of sarcolemmal K(ATP) channels did not modulate the kappa-opioid receptor-mediated increase in cardiac electrical stability. Our results suggest that protein kinase C and mitochondrial K(ATP) channels play an important role in the antiarrhythmic effect associated with activation of peripheral kappa-opioid receptors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17970197     DOI: 10.1007/s10517-007-0046-6

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN: 0007-4888            Impact factor:   0.804


  6 in total

Review 1.  Opioid receptors and cardioprotection - 'opioidergic conditioning' of the heart.

Authors:  John P Headrick; Louise E See Hoe; Eugene F Du Toit; Jason N Peart
Journal:  Br J Pharmacol       Date:  2015-02-27       Impact factor: 8.739

Review 2.  Novel pharmacology: asimadoline, a kappa-opioid agonist, and visceral sensation.

Authors:  M Camilleri
Journal:  Neurogastroenterol Motil       Date:  2008-09       Impact factor: 3.598

3.  The differential effects of a selective kappa-opioid receptor agonist, U50488, in guinea pig heart tissues.

Authors:  Chi-Feng Hung; Hsin-Ju Li; Hsun-Hao Chang; Gon-Ann Lee; Ming Jai Su
Journal:  Biomed Res Int       Date:  2015-03-01       Impact factor: 3.411

4.  Synthesis and evaluation of a novel adenosine-ribose probe for global-scale profiling of nucleoside and nucleotide-binding proteins.

Authors:  Shikha Mahajan; Roman Manetsch; David J Merkler; Stanley M Stevens
Journal:  PLoS One       Date:  2015-02-11       Impact factor: 3.240

5.  A Double-Blind, Placebo-Controlled Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single, Escalating Oral Doses of JDTic.

Authors:  Jeffrey J Buda; F I Carroll; Thomas R Kosten; Dennis Swearingen; Bradford B Walters
Journal:  Neuropsychopharmacology       Date:  2015-01-23       Impact factor: 7.853

6.  Activation of Peripheral Opioid Kappa1 Receptor Prevents Cardiac Reperfusion Injury.

Authors:  S V Popov; A V Mukhomedzyanov; S Y Tsibulnikov; I Khaliuli; P R Oeltgen; N R Prasad; L N Maslov
Journal:  Physiol Res       Date:  2021-06-01       Impact factor: 1.881

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.